Farther Finance Advisors’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.95K Sell
2,148
-322
-13% -$1.69K ﹤0.01% 4753
2026
Q2
$14.3K Buy
2,470
+498
+25% +$3.3K ﹤0.01% 4200
2026
Q1
$13.5K Buy
1,972
+27
+1% +$352 ﹤0.01% 3923
2025
Q4
$33.1K Buy
1,945
+375
+24% +$3.81K ﹤0.01% 3093
2025
Q3
$11.5K Buy
1,570
+59
+4% +$477 ﹤0.01% 3384
2025
Q2
$9.82K Hold
1,511
– – ﹤0.01% 3093
2025
Q1
$11.7K Buy
1,511
+1,500
+13,636% +$16.4K ﹤0.01% 2669
2024
Q4
$136 Hold
11
– – ﹤0.01% 3736
2024
Q3
$90 Hold
11
– – ﹤0.01% 3797
2024
Q2
$58 Sell
11
-15
-58% -$86 ﹤0.01% 3678
2024
Q1
$164 Sell
26
-22
-46% -$110 ﹤0.01% 3307
2023
Q4
$242 Buy
+48
New +$257 ﹤0.01% 3185

Other funds holding WVE

Farther Finance Advisors's WVE Position: Q3 2026 in Review

Farther Finance Advisors reduced its Wave Life Sciences (WVE) stake by 13% in Q3 2026, selling an estimated $1.69K and leaving 2,148 shares worth $7.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4753.

Farther Finance Advisors first reported a position in WVE in Q4 2023 and has held it in 12 quarters since. The position peaked at $33.1K in Q4 2025. 4 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • Farther Finance Advisors held 2,148 shares of Wave Life Sciences worth $7.95K as of Q3 2026.
  • Farther Finance Advisors sold 322 Wave Life Sciences shares in Q3 2026, an estimated $1.69K.
  • Wave Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4753 holding.
  • Farther Finance Advisors first reported a position in Wave Life Sciences in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Wave Life Sciences position peaked at $33.1K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.